Connection

JAMIE ANASTAS to Cell Line, Tumor

This is a "connection" page, showing publications JAMIE ANASTAS has written about Cell Line, Tumor.
Connection Strength

0.269
  1. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell. 2019 11 11; 36(5):528-544.e10.
    View in: PubMed
    Score: 0.089
  2. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. J Clin Invest. 2014 Jul; 124(7):2877-90.
    View in: PubMed
    Score: 0.061
  3. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene. 2012 Aug 09; 31(32):3696-708.
    View in: PubMed
    Score: 0.052
  4. SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells. Elife. 2024 Jun 18; 12.
    View in: PubMed
    Score: 0.031
  5. WLS inhibits melanoma cell proliferation through the ?-catenin signalling pathway and induces spontaneous metastasis. EMBO Mol Med. 2012 Dec; 4(12):1294-307.
    View in: PubMed
    Score: 0.014
  6. Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/?-catenin signaling. J Cell Biol. 2011 Sep 05; 194(5):737-50.
    View in: PubMed
    Score: 0.013
  7. New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Sci Signal. 2008 Nov 11; 1(45):ra12.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.